Robert S. Busch
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Diabetes Management and Research 24
- Diabetes Treatment and Management 23
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 5
- Diabetes, Cardiovascular Risks, and Lipoproteins 4
- Diabetes Management and Education 3
- Surgery 14
- Pancreatic function and diabetes 9
- Co-authors
- Michael P. Kane (28 shared papers)Katherine R. Tuttle (3 shared papers)Brian Rayner (2 shared papers)Fady T. Botros (2 shared papers)Mark Lakshmanan (2 shared papers)Alan G. Zimmermann (2 shared papers)Robert A. Hamilton (15 shared papers)Athena Philis‐Tsimikas (3 shared papers)
- Journals
- Endocrine Practice (5 papers)Diabetes (3 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (3 papers)American Journal of Health-System Pharmacy (3 papers)Diabetes Technology & Therapeutics (2 papers)
- Partner nations
- United StatesDenmarkCanada
In The Last Decade
Robert S. Busch
42 papers receiving 1.3k citations
Robert S. Busch's Hit Papers
Peers
Comparison fields: 5 of 99
- Endocrinology, Diabetes and Metabolism 1.1k
- Nephrology 112
- Pharmacology 247
- Surgery 391
- Molecular Biology 492
Countries citing papers authored by Robert S. Busch
This map shows the geographic impact of Robert S. Busch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Busch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Busch more than expected).
Fields of papers citing papers by Robert S. Busch
This network shows the impact of papers produced by Robert S. Busch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Busch. The network helps show where Robert S. Busch may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert S. Busch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial Hit paper breakdown → | 2018 | 460 |
| 2 | Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial Hit paper breakdown → | 2019 | 267 |
| 3 | Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial Hit paper breakdown → | 2024 | 74 |
| 4 | 2019 | 54 | |
| 5 | 2017 | 45 | |
| 6 | 2007 | 44 | |
| 7 | 2008 | 40 | |
| 8 | 2005 | 39 | |
| 9 | 2004 | 37 | |
| 10 | 2015 | 32 | |
| 11 | 2007 | 20 | |
| 12 | 2006 | 19 | |
| 13 | 2008 | 19 | |
| 14 | 2007 | 18 | |
| 15 | 2003 | 17 | |
| 16 | 2003 | 14 | |
| 17 | 2001 | 13 | |
| 18 | 2006 | 13 | |
| 19 | 2024 | 11 | |
| 20 | 2020 | 11 |
About Robert S. Busch
Robert S. Busch is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Pharmacology and Genetics, having authored 45 papers that have together received 1.3k indexed citations. Recurring topics across this work include Diabetes Management and Research (24 papers), Diabetes Treatment and Management (23 papers), Metabolism, Diabetes, and Cancer (11 papers), Pancreatic function and diabetes (9 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (5 papers), Pharmacology and Obesity Treatment (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Diabetes Management and Education (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.1k citations), Nephrology (112 citations), Pharmacology (247 citations), Surgery (391 citations) and Molecular Biology (492 citations). Robert S. Busch has collaborated with scholars based in United States, Denmark and Canada. Frequent co-authors include Michael P. Kane, Katherine R. Tuttle, Brian Rayner, Fady T. Botros, Mark Lakshmanan, Alan G. Zimmermann, Robert A. Hamilton, Athena Philis‐Tsimikas, Gary Bakst and Desirée Thielke. Their work appears in journals such as Endocrine Practice, Diabetes, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, American Journal of Health-System Pharmacy and Diabetes Technology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.